Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study

The standard treatment for young patients with untreated PTCLs is based on anthracycline containing-regimens followed by high-dose-chemotherapy and stem-cell-transplantation (HDT + SCT), but only 40% of them can be cured. Romidepsin, a histone-deacetylase inhibitor, showed promising activity in rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiappella, Annalisa, Dodero, Anna, Evangelista, Andrea, Re, Alessandro, Orsucci, Lorella, Usai, Sara Veronica, Castellino, Claudia, Stefoni, Vittorio, Pinto, Antonio, Zanni, Manuela, Ciancia, Rosanna, Ghiggi, Chiara, Rossi, Francesca Gaia, Arcari, Annalisa, Ilariucci, Fiorella, Zilioli, Vittorio Ruggero, Flenghi, Leonardo, Celli, Melania, Volpetti, Stefano, Benedetti, Fabio, Ballerini, Filippo, Musuraca, Gerardo, Bruna, Riccardo, Patti, Caterina, Leonardi, Francesco, Arcaini, Luca, Magagnoli, Massimo, Cavallo, Federica, Bermema, Anisa, Tucci, Alessandra, Boccomini, Carola, Ciccone, Giovannino, Carniti, Cristiana, Pileri, Stefano Aldo, Corradini, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898022/
https://www.ncbi.nlm.nih.gov/pubmed/36653509
http://dx.doi.org/10.1038/s41375-022-01780-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898022/
https://www.ncbi.nlm.nih.gov/pubmed/36653509
http://dx.doi.org/10.1038/s41375-022-01780-1

Ejemplares similares